Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Nilotinib | 3.1623 | uM | 3 | 312.50 | 136.54 | 374.00 | 297.50 | 1.2571 | 1.4518 |
| BT-20 | NVP-TAE684 | 0.01 | uM | 3 | 312.50 | 136.54 | 368.00 | 297.50 | 1.2370 | 1.4168 |
| BT-20 | NVP-TAE684 | 0.0033113 | uM | 3 | 312.50 | 136.54 | 314.00 | 297.50 | 1.0555 | 1.0984 |
| BT-20 | 0 | uM | 3 | 312.50 | 136.54 | 437.00 | 297.50 | 1.4689 | 1.8162 | |
| BT-20 | Etoposide | 0.1 | uM | 3 | 312.50 | 136.54 | 428.00 | 297.50 | 1.4387 | 1.7645 |
| BT-20 | PLX-4720 | 0.0033113 | uM | 3 | 312.50 | 136.54 | 437.00 | 297.50 | 1.4689 | 1.8162 |
| BT-20 | Nilotinib | 0.0033113 | uM | 3 | 312.50 | 136.54 | 358.00 | 297.50 | 1.2034 | 1.3582 |
| BT-20 | PLX-4720 | 0.31623 | uM | 3 | 312.50 | 136.54 | 359.00 | 297.50 | 1.2067 | 1.3641 |
| BT-20 | NVP-TAE684 | 0.031623 | uM | 3 | 312.50 | 136.54 | 345.00 | 297.50 | 1.1597 | 1.2819 |
| BT-20 | Nilotinib | 0.31623 | uM | 3 | 312.50 | 136.54 | 385.00 | 297.50 | 1.2941 | 1.5159 |
| BT-20 | NVP-TAE684 | 1 | uM | 3 | 312.50 | 136.54 | 251.00 | 297.50 | 0.8437 | 0.7192 |
| BT-20 | Etoposide | 0.031623 | uM | 3 | 312.50 | 136.54 | 353.00 | 297.50 | 1.1866 | 1.3289 |
| BT-20 | PLX-4720 | 1 | uM | 3 | 312.50 | 136.54 | 282.00 | 297.50 | 0.9479 | 0.9070 |
| BT-20 | PLX-4720 | 0.031623 | uM | 3 | 312.50 | 136.54 | 312.00 | 297.50 | 1.0487 | 1.0865 |
| BT-20 | 0 | uM | 3 | 312.50 | 136.54 | 249.00 | 297.50 | 0.8370 | 0.7070 | |
| BT-20 | 0 | uM | 3 | 312.50 | 136.54 | 223.00 | 297.50 | 0.7496 | 0.5474 | |
| BT-20 | 0 | uM | 3 | 312.50 | 136.54 | 193.00 | 297.50 | 0.6487 | 0.3607 | |
| BT-20 | 0 | uM | 3 | 312.50 | 136.54 | 271.00 | 297.50 | 0.9109 | 0.8406 | |
| BT-20 | Etoposide | 0.01 | uM | 3 | 312.50 | 136.54 | 330.00 | 297.50 | 1.1092 | 1.1933 |
| BT-20 | Etoposide | 0.31623 | uM | 3 | 312.50 | 136.54 | 310.00 | 297.50 | 1.0420 | 1.0746 |
| BT-20 | PLX-4720 | 0.1 | uM | 3 | 312.50 | 136.54 | 340.00 | 297.50 | 1.1429 | 1.2524 |
| BT-20 | Nilotinib | 0.01 | uM | 3 | 312.50 | 136.54 | 288.00 | 297.50 | 0.9681 | 0.9431 |
| BT-20 | Nilotinib | 0.1 | uM | 3 | 312.50 | 136.54 | 287.00 | 297.50 | 0.9647 | 0.9371 |
| BT-20 | Etoposide | 19.9526 | uM | 3 | 312.50 | 136.54 | 169.00 | 297.50 | 0.5681 | 0.2090 |
| BT-20 | PLX-4720 | 0.01 | uM | 3 | 312.50 | 136.54 | 373.00 | 297.50 | 1.2538 | 1.4460 |